Aktis Oncology, Inc. Common stock (AKTS) — Defensive Interval Ratio
Aktis Oncology, Inc. Common stock (AKTS) has a Defensive Interval Ratio of 895 days as of September 2025. Defensive assets of $65.97 Million (cash $-, short-term investments $65.97 Million, receivables $-) cover 895 days of daily cash needs of $73.73K/day. Check AKTS tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Aktis Oncology, Inc. Common stock Defensive Interval Ratio (2017–2024)
This chart shows how Aktis Oncology, Inc. Common stock's Defensive Interval Ratio has evolved across 15 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 895 days, meaning defensive assets of $65.97 Million can fund 895 days of operations without new revenue. Also explore Aktis Oncology, Inc. Common stock (AKTS) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Aktis Oncology, Inc. Common stock (2017–2024)
The table below presents the year-by-year Defensive Interval Ratio for Aktis Oncology, Inc. Common stock from 2017 to 2024, covering 15 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Aktis Oncology, Inc. Common stock.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 5145 days | $265.30 Million | $51.57K/day | $- | $260.01 Million | ▲ +5122 days |
| 2024 | 23 days | $5.29 Million | $231.15K/day | $- | $- | ▼ -4255 days |
| 2023 | 4278 days | $73.10 Million | $17.09K/day | $- | $68.35 Million | ▲ +4179 days |
| 2023 | 99 days | $4.75 Million | $48.14K/day | $- | $- | ▲ +99 days |
| 2022 | 0 days | $0.00 | $14.45K/day | $- | $0.00 | ▼ -109 days |
| 2022 | 109 days | $3.79 Million | $34.68K/day | $- | $- | ▲ +0 days |
| 2021 | 109 days | $3.79 Million | $34.68K/day | $- | $- | ▲ +51 days |
| 2021 | 59 days | $1.17 Million | $19.90K/day | $- | $- | ▲ +38 days |
| 2020 | 21 days | $351.00K | $16.79K/day | $- | $- | ▲ +0 days |
| 2020 | 21 days | $351.00K | $16.79K/day | $- | $- | ▼ -11 days |
| 2019 | 32 days | $285.00K | $8.81K/day | $- | $- | ▲ +0 days |
| 2019 | 32 days | $285.00K | $8.81K/day | $- | $- | ▲ +3 days |
| 2018 | 30 days | $214.66K | $7.25K/day | $- | $- | ▲ +0 days |
| 2018 | 30 days | $214.66K | $7.25K/day | $- | $- | ▼ -13 days |
| 2017 | 43 days | $158.46K | $3.70K/day | $- | $- | — |